Foghorn Therapeutics Inc (FHTX)

Mar 12, 2026

Foghorn Therapeutics (FHTX) FY 2025 Losses Reinforce Bearish Unprofitability Narrative - simplywall.st

Mar 12, 2026

Mar 12, 2026

Jefferies reiterates Foghorn Therapeutics stock rating on pipeline data - Investing.com Australia

Mar 12, 2026

Mar 12, 2026

Foghorn Therapeutics reports $158.9M cash position, extends runway - Investing.com Australia

Mar 12, 2026

Mar 12, 2026

Stifel reiterates Foghorn Therapeutics stock rating at buy By Investing.com - Investing.com Australia

Mar 12, 2026

Mar 12, 2026

Stifel reiterates Foghorn Therapeutics stock rating at buy - Investing.com

Mar 12, 2026

Mar 12, 2026

Foghorn Therapeutics: Pioneering Precision Oncology with Chromatin Regulatory System Targeting and Gene Traffic Control Platform - Minichart

Mar 12, 2026

Mar 11, 2026

Foghorn Advances FHD-909 Trial and Strengthens Financial Position - TipRanks

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics Inc. (FHTX) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics 10-K: $30.9M revenue, $(1.18) EPS - TradingView

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics (NASDAQ:FHTX) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook - GlobeNewswire

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics (NASDAQ:FHTX) Given Buy Rating at HC Wainwright - Defense World

Mar 11, 2026

Mar 10, 2026

HC Wainwright Reiterates Buy Rating for Foghorn Therapeutics (NASDAQ:FHTX) - MarketBeat

Mar 10, 2026

Mar 10, 2026

HC Wainwright Reiterates Buy Rating for Foghorn Therapeutics (FH - GuruFocus

Mar 10, 2026

Mar 08, 2026

Aug Volume: Is Foghorn Therapeutics Inc part of any major index2026 Action & Low Volatility Stock Recommendations - baoquankhu1.vn

Mar 08, 2026

Mar 07, 2026

Will Foghorn Therapeutics Inc. stock benefit from AI adoptionForecast Cut & Smart Investment Allocation Insights - Naître et grandir

Mar 07, 2026

Mar 06, 2026

Foghorn Therapeutics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView

Mar 06, 2026

Mar 04, 2026

FHTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026

Mar 03, 2026

TD Cowen Health Care Conference - marketscreener.com

Mar 03, 2026

Feb 28, 2026

Should you avoid Foghorn Therapeutics Inc. stock right nowJuly 2025 Volume & Short-Term Trading Alerts - mfd.ru

Feb 28, 2026

Feb 26, 2026

Foghorn Therapeutics (FHTX) Projected to Post Earnings on Thursday - Defense World

Feb 26, 2026

Feb 24, 2026

Foghorn Therapeutics (FHTX) grants CFO 400,000 stock options - Stock Titan

Feb 24, 2026

Feb 24, 2026

Foghorn Therapeutics (FHTX) CFO files Form 3 insider ownership - Stock Titan

Feb 24, 2026

Feb 24, 2026

Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences - Investing News Network

Feb 24, 2026

Feb 24, 2026

Foghorn Therapeutics names Ryan Maynard as chief financial officer By Investing.com - Investing.com India

Feb 24, 2026

Feb 24, 2026

Cancer-focused biotech Foghorn to present at two March investor forums - Stock Titan

Feb 24, 2026

Feb 24, 2026

FHTXFoghorn Therapeutics Inc. Latest Stock News & Market Updates - Stock Titan

Feb 24, 2026

Feb 23, 2026

Foghorn Therapeutics names Ryan Maynard as chief financial officer - Investing.com

Feb 23, 2026

Feb 23, 2026

Foghorn Therapeutics (FHTX) Appoints New CFO with Extensive Expe - GuruFocus

Feb 23, 2026

Feb 23, 2026

Foghorn Therapeutics Appoints Ryan Maynard CFO - marketscreener.com

Feb 23, 2026

Feb 23, 2026

Foghorn Therapeutics Names Veteran Executive as New CFO - TipRanks

Feb 23, 2026

Feb 23, 2026

Foghorn Therapeutics Inc. Appoints Ryan Maynard as Chief Financial Officer - Quiver Quantitative

Feb 23, 2026

Feb 23, 2026

Ryan Maynard joins Foghorn Therapeutics (NASDAQ: FHTX) as new CFO - Stock Titan

Feb 23, 2026

Feb 23, 2026

Foghorn Therapeutics Inc. Announces Executive Changes - marketscreener.com

Feb 23, 2026

Feb 20, 2026

Will Foghorn Therapeutics Inc. (FHTX) Report Negative Q4 Earnings? What You Should Know - MSN

Feb 20, 2026

Feb 20, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Qiagen (QGEN) and Foghorn Therapeutics (FHTX) - The Globe and Mail

Feb 20, 2026

Feb 19, 2026

Investment Review: Does Aris Mining Corporation have a competitive edgeQuarterly Portfolio Summary & Verified Entry Point Detection - baoquankhu1.vn

Feb 19, 2026

Feb 19, 2026

Jefferies Financial Group Begins Coverage on Foghorn Therapeutics (NASDAQ:FHTX) - Defense World

Feb 19, 2026

Feb 17, 2026

Jefferies Lowers Price Target for Foghorn Therapeutics (FHTX) to $12.00 | FHTX Stock News - GuruFocus

Feb 17, 2026

Feb 17, 2026

Jefferies initiates Foghorn Therapeutics stock with buy rating By Investing.com - Investing.com Nigeria

Feb 17, 2026

Feb 17, 2026

Jefferies initiates Foghorn Therapeutics stock with buy rating - Investing.com

Feb 17, 2026

Feb 16, 2026

Can Foghorn Therapeutics Inc. stock double in the next yearProduct Launch & High Accuracy Investment Signals - mfd.ru

Feb 16, 2026

Feb 15, 2026

Foghorn Therapeutics appoints interim CFO Jeff Sacher - MSN

Feb 15, 2026

Feb 14, 2026

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Feb 14, 2026

Feb 14, 2026

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Rating of “Buy” from Brokerages - Defense World

Feb 14, 2026

Feb 13, 2026

Foghorn Therapeutics CEO Talks Lilly-Partnered SMARCA2 Phase 1 and New Degrader Targets at Conference - MarketBeat

Feb 13, 2026

Feb 12, 2026

Does Foghorn Therapeutics Inc. have strong fundamentalsWeekly Trade Report & Verified Short-Term Plans - mfd.ru

Feb 12, 2026

Feb 12, 2026

Foghorn Therapeutics (NASDAQ:FHTX) Stock Price Down 0.6%Should You Sell? - MarketBeat

Feb 12, 2026